Suchergebnisse - (Subject:"Drug Combinations")

PubPharm (801)

1

Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Papini, C. | Ullah, I. | Ranjan, A. | +11

2

Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19

enthalten in: BMJ open respiratory research | 2024

von Zhang, H. | Xiaojiao, T. | Chen, J. | +8

3

AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans

enthalten in: Science immunology | 2024

von Grigoryan, L. | Feng, Y. | Bellusci, L. | +20

4

The metabolic footprint of Vero E6 cells highlights the key metabolic routes associated with SARS-CoV-2 infection and response to drug combinations

enthalten in: Scientific reports | 2024

von Melis, R. | Braca, A. | Pagnozzi, D. | +1

5

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2024

von Hammond, J. | Fountaine, R. | Yunis, C. | +10

6

Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Xu, S. | Esmaeili, S. | Cardozo-Ojeda, E. | +4

7

Comprehensive performance evaluation of ligand-binding assay-LC-MS/MS method for co-dosed monoclonal anti-SARS-CoV-2 antibodies (AZD7442)

enthalten in: Bioanalysis | 2024

von Huang, Y. | Woolf, M. | Wang, C. | +5

8

Ceftazidime-avibactam alone or in combination with Aztreonam versus Polymyxins in the management of carbapenem-Resistant Klebsiella pneumoniae nosocomial Infections (CAPRI study) : a retrospective cohort study from South India

enthalten in: Infection | 2024

von Sree, R. | Gupta, A. | Gupta, N. | +10

9

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of infection | 2024

von Hites, M. | Lapique, E. | Massonnaud, C. | +84

10

Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses

enthalten in: mBio | 2024

von Davis, K. | Morales, Y. | Ende, R. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[81]